Sensex, Nifty skids into negative terrain; Nifty below 17,200 level

Image
Capital Market
Last Updated : Mar 24 2022 | 4:31 PM IST

The benchmark indices witnessed major volatility during early afternoon trade. Banks stocks dragged the indices lower while metal and pharma scrips supported. The Nifty slipped below its 17,200 mark.

At 12:30 IST, the barometer index, the S&P BSE Sensex dropped 279.94 points or 0.49% at 57,404.88. The Nifty 50 index lost 71.90 points or 0.42% at 17,173.75.

The S&P BSE Mid-Cap index rose 0.23%. The S&P BSE Small-Cap index gained 0.10%.

The market breadth, indicating the overall health of the market, was negative. On the BSE, shares 1,467 rose and 1,788 shares fell. A total of 137 shares were unchanged.

Derivatives:

The NSE's India VIX, a gauge of market's expectation of volatility over the near term, fell 0.07% to 24.73. The Nifty 31 March 2022 futures were trading at 17,189.85, at a premium of 16.10 points as compared with the spot at 17,173.75.

The Nifty option chain for 31 March 2022 expiry showed maximum Call OI of 82.61 lakh contracts at the 18,000 strike price. Maximum Put OI of 103.32 lakh contracts was seen at 16,000 strike price.

Buzzing Index:

The Nifty Pharma index rose 1.13% to 13,722.35. The index gained 1.54% in two trading sessions.

Dr Reddy's Laboratories (up 3.96%), Lupin (up 3.38%), Aurobindo Pharma (up 3.31%), Glenmark Pharmaceuticals (up 2.15%) and Granules India (up 1.99%) were the gainers in the Pharma segment.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 24 2022 | 12:40 PM IST

Next Story